Oscar Health, Inc.
OSCR NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
0.40
EPS Actual
1.10
Revenue Est.
$4.73B
Revenue Actual
$4.79B
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.27
Revenue Est.
$4.7B
Company Overview
Oscar Health, Inc. (ticker OSCR) is listed on NYSE with a market cap of about $8.31B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of -0.27. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Feb 9, 2023 → Aug 6, 2026
Feb 9, 2023Range: -1.24 ~ 2.07Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | 0.40 | Above forecast↑1.10 | $4.73B | $4.79B |
| May 6, 2026 | -- | 1.21 | Above forecast↑2.07 | $4.89B | $4.58B |
| Feb 10, 2026 | -- | -0.92 | Below forecast↓-1.24 | $3.12B | $2.75B |
| Nov 6, 2025 | -- | -0.55 | -0.53 | $3.05B | $2.99B |
| Aug 6, 2025 | -- | -0.90 | -0.89 | $3.07B | $2.86B |
| May 7, 2025 | -- | 0.83 | 0.92 | $2.78B | $3.05B |
| Feb 4, 2025 | -- | -0.55 | -0.62 | $2.83B | $2.39B |
| Nov 7, 2024 | -- | -0.20 | -0.22 | $2.34B | $2.42B |
| Aug 7, 2024 | -- | 0.16 | Above forecast↑0.20 | $2.15B | $2.22B |
| May 7, 2024 | -- | 0.27 | Above forecast↑0.62 | $2.15B | $2.14B |
| Feb 7, 2024 | -- | -0.74 | -0.66 | $1.42B | $1.43B |
| Nov 7, 2023 | -- | -0.47 | Above forecast↑-0.29 | $1.42B | $1.44B |
| Aug 8, 2023 | -- | -0.33 | Above forecast↑-0.07 | $1.44B | $1.52B |
| May 9, 2023 | -- | -0.05 | Below forecast↓-0.18 | $1.15B | $1.47B |
| Feb 9, 2023 | -- | -1.01 | -1.05 | $1.18B | $1.04B |
Original Filings (SEC)
10-Q2026-08-07 ↗
8-K2026-08-06 ↗
8-K2026-06-09 ↗
8-K2026-06-08 ↗
8-K2026-06-02 ↗
10-Q2026-05-07 ↗
8-K2026-05-06 ↗
8-K2026-04-21 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
